| Product Code: ETC12130821 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Exocrine Pancreatic Insufficiency Diagnostics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 China Exocrine Pancreatic Insufficiency Diagnostics Market - Industry Life Cycle |
3.4 China Exocrine Pancreatic Insufficiency Diagnostics Market - Porter's Five Forces |
3.5 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By Diagnostic Type, 2021 & 2031F |
3.6 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By Diagnostic Tool, 2021 & 2031F |
3.7 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Exocrine Pancreatic Insufficiency Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of exocrine pancreatic insufficiency in China |
4.2.2 Growing awareness about early diagnosis and treatment of pancreatic disorders |
4.2.3 Technological advancements in diagnostic tools and techniques |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for pancreatic diagnostics in certain regions of China |
4.3.2 High cost associated with diagnostic tests and procedures |
4.3.3 Lack of skilled healthcare professionals trained in diagnosing exocrine pancreatic insufficiency |
5 China Exocrine Pancreatic Insufficiency Diagnostics Market Trends |
6 China Exocrine Pancreatic Insufficiency Diagnostics Market, By Types |
6.1 China Exocrine Pancreatic Insufficiency Diagnostics Market, By Diagnostic Type |
6.1.1 Overview and Analysis |
6.1.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Diagnostic Type, 2021 - 2031F |
6.1.3 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.1.4 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.1.5 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Imaging Tests, 2021 - 2031F |
6.1.6 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Fecal Fat Analysis, 2021 - 2031F |
6.2 China Exocrine Pancreatic Insufficiency Diagnostics Market, By Diagnostic Tool |
6.2.1 Overview and Analysis |
6.2.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Genetic Screening Kits, 2021 - 2031F |
6.2.3 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Enzyme Activity Tests, 2021 - 2031F |
6.2.4 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By MRI and CT Scan, 2021 - 2031F |
6.2.5 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Stool Sample Testing, 2021 - 2031F |
6.3 China Exocrine Pancreatic Insufficiency Diagnostics Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By PCR and DNA Sequencing, 2021 - 2031F |
6.3.3 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Blood Sampling, 2021 - 2031F |
6.3.4 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Radiology-based Imaging, 2021 - 2031F |
6.3.5 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Enzyme Activity Detection, 2021 - 2031F |
6.4 China Exocrine Pancreatic Insufficiency Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Patients with Genetic Disorders, 2021 - 2031F |
6.4.3 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Pancreatic Disease Patients, 2021 - 2031F |
6.4.4 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.4.5 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Gastroenterologists, 2021 - 2031F |
7 China Exocrine Pancreatic Insufficiency Diagnostics Market Import-Export Trade Statistics |
7.1 China Exocrine Pancreatic Insufficiency Diagnostics Market Export to Major Countries |
7.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Imports from Major Countries |
8 China Exocrine Pancreatic Insufficiency Diagnostics Market Key Performance Indicators |
8.1 Average time taken for diagnosis of exocrine pancreatic insufficiency |
8.2 Adoption rate of advanced diagnostic technologies for pancreatic disorders |
8.3 Patient satisfaction scores related to the diagnostic process |
8.4 Number of research studies and clinical trials focusing on exocrine pancreatic insufficiency in China |
8.5 Rate of referrals from primary care physicians to specialists for pancreatic diagnostic evaluations |
9 China Exocrine Pancreatic Insufficiency Diagnostics Market - Opportunity Assessment |
9.1 China Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By Diagnostic Type, 2021 & 2031F |
9.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By Diagnostic Tool, 2021 & 2031F |
9.3 China Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 China Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Exocrine Pancreatic Insufficiency Diagnostics Market - Competitive Landscape |
10.1 China Exocrine Pancreatic Insufficiency Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 China Exocrine Pancreatic Insufficiency Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here